Ghrelin and obestatin levels in end-stage renal disease

Journal of International Medical Research

Volumn 37, Issue 3, 2009, Pages 757-765

  Aygen, Bilge ^a   Dogukan, A ^a   Dursun, F E ^a   Aydin, S ^a   Kilic, N ^a   Sahpaz, F ^a   Celiker, H ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

End stage renal disease; Ghrelin; Nutrition regulating hormones; Obestatin

Indexed keywords

ALBUMIN; GHRELIN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OBESTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; SALIVA LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; DEMOGRAPHY; METABOLISM; MIDDLE AGED; SALIVA;

ADULT; DEMOGRAPHY; GHRELIN; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; SALIVA;

EID: 70349229417     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700319     Document Type: Article

References (46)

1. Mak RH, Cheung W: Adipokines and gut hormones in end-stage renal disease. Perit Dial Int 2007; 27(suppl 2): S298-S302. (Pubitemid 350047718)
2. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 1996; 50: 343-357.
3. Kopple JD: Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 1999; 129(1S suppl): 247S-251S.
4. Wren AM, Seal LJ, Cohen MA, et al: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5995.
5. Wren AM, Small CJ, Abbott CR, et al: Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540-2547. (Pubitemid 33642772)
6. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
7. Kojima M, Hosoda H, Date Y, et al: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660. (Pubitemid 129516334)
8. Date Y, Kojima M, Hosoda H, et al: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261. (Pubitemid 30953541)
9. Mori K, Yoshimoto A, Takaya K, et al: Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000; 486: 213-216.
10. Yoshimoto A, Mori K, Sugawara A, et al: Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-2752. (Pubitemid 35216044)
11. Zhang JV, Ren PG, Avsian-Kretchmer O, et al: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999. (Pubitemid 41611907)
12. Zhao CM, Furnes MW, Stenstrom B, et al: Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575-587.
13. Tang SQ, Jiang QY, Zhang YL et al: Obestatin: its physicochemical characteristics and physiological functions. Peptides 2008; 29: 639-645.
14. Lagaud GJ, Young A, Acena A, et al: Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 2007; 357: 264-269. (Pubitemid 46574526)
15. Green BD, Irwin N, Flatt PR: Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007; 28: 981-987. (Pubitemid 46654435)
16. Gourcerol G, St-Pierre DH, Taché Y: Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 2007; 141: 1-7. (Pubitemid 46505037)
17. Nogueiras R, Pfluger P, Tovar S, et al: Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148: 21-26. (Pubitemid 46021434)
18. Gourcerol G, Coskun T, Craft LS, et al: Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 2007; 15: 2643-2652.
19. De Smet B, Thijs T, Peeters TL, et al: Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 2007; 19: 211-217. (Pubitemid 46239433)
20. Fujimiya M, Asakawa A, Ataka K, et al: Different effects of ghrelin, des-acyl ghrelin and obestatin on gastroduodenal motility in conscious rats. World J Gastroenterol 2008; 14: 6318-6326.
21. Katergari SA, Milousis A, Pagonopoulou O, et al: Ghrelin in pathological conditions. Endocr J 2008; 55: 439-453.
22. Leite-Moreira AF, Soares JB: Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 2007; 12: 276-288. (Pubitemid 46467484)
23. Yabuki A, Taharaguchi S, Ichii O, et al: Immunohistochemical localization of ghrelin in rodent kidneys. Histochem Cell Biol 2006; 126: 231-238.
24. Hosoda H, Kojima M, Matsuo H, et al: Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-913. (Pubitemid 32042875)
25. Asakawa A, Inui A, Fujimiya M, et al: Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005; 54: 18-24. (Pubitemid 40007213)
26. Gil-Campos M, Aguilera CM, Canete R, et al: Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 2006; 96: 201-226. (Pubitemid 46476321)
27. Chen CY, Chao Y, Chang FY, et al: Intracisternal des-acyl ghrelin inhibits food intake and nonnutrient gastric emptying in conscious rats. Int J Mol Med 2005; 16: 695-699.
28. Chen CY, Inui A, Asakawa A, et al: Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005; 129: 8-25. (Pubitemid 41002038)
29. Inhoff T, Monnikes H, Noetzel S, et al: Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008; 29: 2159-2168. (Pubitemid 50320433)
30. Toshinai K, Yamaguchi H, Sun Y, et al: Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006; 147: 2306-2314.
31. Cummings DE, Weigle DS, Frayo RS, et al: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630. (Pubitemid 34755670)
32. Marzullo P, Verti B, Savia G, et al: The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004; 89: 936-939. (Pubitemid 38269914)
33. Dostálová I, Haluzík M: The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res 2008 [epub ahead of print].
34. Hotta M, Ohwada R, Katakami H, et al: Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 2004; 89: 5707-5712. (Pubitemid 39518462)
35. Aguilera A, Cirugeda A, Amair R, et al: Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial 2004; 20: 194-199.
36. Muscaritoli M, Molfino A, Chiappini MG, et al: Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 2007; 27: 360-365. (Pubitemid 47082396)
37. Cummings DE: Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006; 89: 71-84.
38. Purnell JQ, Weigle DS, Breen P, et al: Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003; 88: 5747-5752. (Pubitemid 38033045)
39. Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, et al: Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004; 19: 421-426. (Pubitemid 38195993)
40. Iglesias P, Diez JJ, Fernandez-Reyes MJ, et al: Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol (Oxf) 2006; 64: 68-73.
41. Jarkovská Z, Hodková M, Sazamová M, et al: Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis. Growth Horm IGF Res 2005; 15: 369-376. (Pubitemid 41683803)
42. Groschl M, Topf HG, Bohlender J, et al: Identification of ghrelin in human saliva: production by the salivary glands and potential role in proliferation of oral keratinocytes. Clin Chem 2005; 51: 997-1006. (Pubitemid 40740880)
43. Aydin S, Halifeoglu I, Ozercan IH, et al: A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides 2005; 26: 647-652. (Pubitemid 40326883)
44. Zamrazilova H, Hainer V, Sedlackova D, et al: Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 2008; 57(suppl 1): S49-S55.
45. Nakahara T, Harada T, Yasuhara D, et al: Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008; 64: 252-255. (Pubitemid 351927261)
46. Vergote V, Van Dorpe S, Peremans K, et al: In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides 2008; 29: 1740-1748.